ACAD

NASDAQ HEALTHCARE

ACADIA Pharmaceuticals Inc

$25.80

$0.41 (+1.61%)

Live quote

52w: $19.69 – $28.35

Loading chart…

P/E Ratio11.12

P/B Ratio3.48

EV/EBITDA—

Debt/Equity—

ROE31.33%

ROIC—

Revenue Growth11.87%

Gross Margin63.91%

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company is headquartered in San Diego, California.

Own ACAD? Track it here.

Create a free account to add ACAD to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account